These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2849904)

  • 1. Blood lymphocyte beta-adrenergic receptors in multiple sclerosis.
    Arnason BG; Brown M; Maselli R; Karaszewski J; Reder A
    Ann N Y Acad Sci; 1988; 540():585-8. PubMed ID: 2849904
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.
    Karaszewski JW; Reder AT; Maselli R; Brown M; Arnason BG
    Ann Neurol; 1990 Apr; 27(4):366-72. PubMed ID: 2162144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation in rapidly progressive multiple sclerosis.
    Arnason BG; Noronha AB; Reder AT
    Ann N Y Acad Sci; 1988; 540():4-12. PubMed ID: 2905124
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased high affinity beta-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis.
    Karaszewski JW; Reder AT; Anlar B; Arnason GW
    J Neuroimmunol; 1993 Mar; 43(1-2):1-7. PubMed ID: 8384633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lymphocyte beta-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell.
    Karaszewski JW; Reder AT; Anlar B; Kim WC; Arnason BG
    Ann Neurol; 1991 Jul; 30(1):42-7. PubMed ID: 1656847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nervous system-immune system interactions and their role in multiple sclerosis.
    Chelmicka-Schorr E; Arnason BG
    Ann Neurol; 1994; 36 Suppl():S29-32. PubMed ID: 8017886
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic ablation alters lymphocyte membrane properties.
    Miles K; Chelmicka-Schorr E; Atweh S; Otten G; Arnason BG
    J Immunol; 1985 Aug; 135(2 Suppl):797s-801s. PubMed ID: 2861234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subsets in the multiple sclerosis lesion.
    Sobel RA
    Res Immunol; 1989 Feb; 140(2):208-11; discussion 245-8. PubMed ID: 2500682
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice.
    Zipris D; Crow AR; Delovitch TL
    Diabetes; 1991 Apr; 40(4):429-35. PubMed ID: 1826279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
    Maimone D; Reder AT
    Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a physical load on the adrenergic receptor function of peripheral blood lymphocytes and thrombocytes in healthy donors].
    Korichneva IL; Krasnikova TL; Buravkova LB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):83-7. PubMed ID: 3038142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.
    Maisel AS; Knowlton KU; Fowler P; Rearden A; Ziegler MG; Motulsky HJ; Insel PA; Michel MC
    J Clin Invest; 1990 Feb; 85(2):462-7. PubMed ID: 2153706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.
    Cryer PE
    N Engl J Med; 1980 Aug; 303(8):436-44. PubMed ID: 6248784
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal alpha-adrenergic mechanisms in diabetes mellitus.
    Robertson RP; Beiter HL; Porte D
    Lancet; 1973 Feb; 1(7799):370. PubMed ID: 4121958
    [No Abstract]   [Full Text] [Related]  

  • 15. T-lymphocyte requirement for diabetes in RT6-depleted diabetes-resistant BB rats.
    Woda BA; Handler ES; Greiner DL; Reynolds C; Mordes JP; Rossini AA
    Diabetes; 1991 Apr; 40(4):423-8. PubMed ID: 1707018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of RPMI 8226 human myeloma cells by peripheral blood lymphocytes.
    Amano T; Katagiri S; Tominaga N; Oritani K; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
    Acta Haematol; 1992; 87(1-2):37-44. PubMed ID: 1350158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
    Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
    Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic dysfunction (sweating responses) in multiple sclerosis.
    Noronha MJ; Vas CJ; Aziz H
    J Neurol Neurosurg Psychiatry; 1968 Feb; 31(1):19-22. PubMed ID: 5644926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis.
    Habek M; Crnošija L; Lovrić M; Junaković A; Krbot Skorić M; Adamec I
    Clin Auton Res; 2016 Dec; 26(6):385-393. PubMed ID: 27448576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.